A Biotech ETF Gets Its Groove Back

A Biotech ETF Gets Its Groove Back


After struggling through one of its worst annual performances in several years in 2016, the SPDR S&P Biotech ETF , the third-largest biotechnology exchange traded fund, is surging to start 2017.



from Biotech News